6 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
of SGLT2 inhibitors ... in CVD and CKD ... HF outcomes in HFrEF ... HF outcomes in HFrEF ... #EBM #trial #visualabstract
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
angiotensin-converting enzyme inhibitor ... ejection fraction; GDMT ... heart failure; HFpEF ... heart failure with preserved ... ejection fraction; HFrEF
Heart Failure with Preserved Ejection Fraction: Management Principles

General Therapeutic Principles:
Reduce the congestive state 
 - Caution
Heart Failure with Preserved ... hypertension, pulmonary ... #Management #Cardiology ... #HFpEF #dCHF #Diastolic ... #Treatment #HeartFailure
TOPCAT - Spironolactone for Heart Failure with Preserved Ejection Fraction

N Engl J Med 2014; 370:1383-1392 https://www.nejm.org/doi/10.1056/NEJMoa1313731

CONCLUSIONS:
ejection fraction, treatment ... Spironolactone #HFpEF ... #dCHF #Cardiology ... #EBM #VisualAbstract ... #Trial
Iron Deficiency in Heart Failure
Pathophysiology:
Chronic heart failure leads to an increase in inflammatory cytokines → Inflammation
functional ID) Treatment ... mortality and CV ... #deficiency #CHF ... #HFrEF #heartfailure ... diagnosis #management #cardiology
Severe Heart Failure & Cardiogenic Shock - Management Checklist 
Evaluation 
 - EKG & echocardiography
another option in HFrEF ... milrinone) for HFrEF ... With chronic AF, HFrEF ... NSAlDs, ACE-inhibitors ... #HeartFailure #Cardiology